ANLONG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ANLONG - overview
Established
2019
Location
Beijing, -, China
Primary Industry
Biotechnology
About
Based in Beijing, China and founded in 2019, Beijing Anlong Biomedical Co. , Ltd. , trading as ANLONG, operas as a gene therapy company which focuses on ophthalmology. The company has a 5000 square meter R&D and GMP production base in zhongguancun medical transformation center.
The founder and CEO, Zhao Chunlin, has more than 30 years entrepreneurship and investment experience in the field of scientific research, multinational pharmaceutical companies, domestic pharmaceuticals and medical instrument. In January 2026, ANLONG raised approximately CNY 100 million in Series B+ funding from new investors Shunyi Industry Capital and Shunxi Fund. ANLONG focuses on nucleic acid drugs, include gene therapy, gene editing, RNA drugs, oncolytic viruses and other new drug development technology. Besides, the company focuses on gene therapy of wet macular degeneration wAMD and AAV vector screening.
The company mainly focuses on the field of ophthalmology, blood, neuromuscular system and cardio-cerebrovascular system. The company generates revenue by developing new drugs using technologies such as gene regulation, gene therapy, and gene editing. The funding raised in January 2026 will be used to advance the research and clinical translation of its gene therapy project for wet age-related macular degeneration (wAMD) and its AAV vector screening technology.
Current Investors
Yingke Private Equity, HighLight Capital, Oceanpine Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Optometrists & Opticians Products and Services, Pharmaceutical Research & Development
Website
www.anlongbio.com
Verticals
HealthTech, Manufacturing
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.